Authors:
Bernard, GR
Ely, EW
Wright, TJ
Fraiz, J
Stasek, JE
Russell, JA
Mayers, I
Rosenfeld, BA
Morris, PE
Yan, SB
Helterbrand, JD
Citation: Gr. Bernard et al., Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis, CRIT CARE M, 29(11), 2001, pp. 2051-2059
Citation: Jw. Zhou et al., Striatal extracts promote the survival and phenotypic expression of rat fetal dopaminergic neurons in vitro, NEUROSCI L, 292(1), 2000, pp. 5-8
Citation: Cj. Fisher et Sb. Yan, Protein C levels as a prognostic indicator of outcome in sepsis and related diseases, CRIT CARE M, 28(9), 2000, pp. S49-S56
Citation: Rm. Mesters et al., Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications, CRIT CARE M, 28(7), 2000, pp. 2209-2216
Citation: Sb. Yan et Cj. Fisher, Activated protein C differs from protein C pharmacokinetically and pharmacodynamically, SHOCK, 12(3), 1999, pp. 243-243